Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rodger, F. E.
Right arrow Articles by Illingworth, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodger, F. E.
Right arrow Articles by Illingworth, P. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 12, 1723-1729, Copyright © 1997 by Oxford University Press


ARTICLES

Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum

FE Rodger, FM Young, HM Fraser and PJ Illingworth
MRC Reproductive Biology Unit, Centre for Reproductive Biology, Edinburgh, UK.

The corpus luteum is essential for the maintenance of early pregnancy in women. Angiogenesis may be one factor involved in luteal rescue. The aim of this study was to determine the changes in endothelial cell proliferation throughout the luteal phase and in human chorionic gonadotrophin (HCG)-simulated early pregnancy. Human corpora lutea obtained throughout the luteal phase and in simulated early pregnancy were immunostained with antibodies for endothelial and proliferating cells. Number and distribution of endothelial and proliferating cells were examined. Endothelial cells were least abundant in the early luteal phase, increasing in the mid-luteal phase (P < 0.03). Endothelial numbers did not differ significantly between the late and the rescued corpora lutea. Endothelial cell proliferation was greatest in the early luteal phase and continued at a lower level during later stages. Simulated early pregnancy resulted in no change in endothelial cell proliferation. These results showed that a high degree of endothelial cell proliferation is associated with formation of the human corpus luteum. Unchanging levels of proliferation following HCG treatment (for 5-8 days from day 12 to day 16 post-ovulation, at 125 IU to 16,000 IU, following a daily doubling of dose) suggest that alternative processes are involved during luteal rescue.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
I. Y. Jarvela, A. Ruokonen, and A. Tekay
Effect of rising hCG levels on the human corpus luteum during early pregnancy
Hum. Reprod., December 1, 2008; 23(12): 2775 - 2781.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. van den Driesche, M. Myers, E. Gay, K. J. Thong, and W. C. Duncan
HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum
Mol. Hum. Reprod., August 1, 2008; 14(8): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Groten, H.M. Fraser, W.C. Duncan, R. Konrad, R. Kreienberg, and C. Wulff
Cell junctional proteins in the human corpus luteum: changes during the normal cycle and after HCG treatment
Hum. Reprod., December 1, 2006; 21(12): 3096 - 3102.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Sugino, T. Suzuki, A. Sakata, I. Miwa, H. Asada, T. Taketani, Y. Yamagata, and H. Tamura
Angiogenesis in the Human Corpus Luteum: Changes in Expression of Angiopoietins in the Corpus Luteum throughout the Menstrual Cycle and in Early Pregnancy
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6141 - 6148.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. J. Rowe, K. D. Morris, R. Bicknell, and H. M. Fraser
Angiogenesis in the Corpus Luteum of Early Pregnancy in the Marmoset and the Effects of Vascular Endothelial Growth Factor Immunoneutralization on Establishment of Pregnancy
Biol Reprod, October 1, 2002; 67(4): 1180 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Wulff, S. E. Dickson, W. C. Duncan, and H. M. Fraser
Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization
Hum. Reprod., December 1, 2001; 16(12): 2515 - 2524.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wulff, H. Wilson, J. S. Rudge, S. J. Wiegand, S. F. Lunn, and H. M. Fraser
Luteal Angiogenesis: Prevention and Intervention by Treatment with Vascular Endothelial Growth Factor TrapA40
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3377 - 3386.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wulff, H. Wilson, P. Largue, W. C. Duncan, D. G. Armstrong, and H. M. Fraser
Angiogenesis in the Human Corpus Luteum: Localization and Changes in Angiopoietins, Tie-2, and Vascular Endothelial Growth Factor Messenger Ribonucleic Acid
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4302 - 4309.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Dickson and H. M. Fraser
Inhibition of Early Luteal Angiogenesis by Gonadotropin-Releasing Hormone Antagonist Treatment in the Primate
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2339 - 2344.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. M. Fraser, S. F. Lunn, H. Kim, W. C. Duncan, F. E. Rodger, P. J. Illingworth, and G. F. Erickson
Changes in Insulin-like Growth Factor-Binding Protein-3 Messenger Ribonucleic Acid in Endothelial Cells of the Human Corpus Luteum: A Possible Role in Luteal Development and Rescue
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1672 - 1677.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. M. Fraser, S. E. Dickson, S. F. Lunn, C. Wulff, K. D. Morris, V. A. Carroll, and R. Bicknell
Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor
Endocrinology, March 1, 2000; 141(3): 995 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F.M. Young, F.E. Rodger, P.J. Illingworth, and H.M. Fraser
Cell proliferation and vascular morphology in the marmoset corpus luteum
Hum. Reprod., March 1, 2000; 15(3): 557 - 566.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K. H. Plate, and H. G. Augustin
Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies
Cancer Res., March 1, 2000; 60(5): 1388 - 1393.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Otani, S. Minami, M. Yamoto, T. Shikone, H. Otani, R. Nishiyama, T. Otani, and R. Nakano
The Vascular Endothelial Growth Factor/fms-Like Tyrosine Kinase System in Human Ovary during the Menstrual Cycle and Early Pregnancy
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3845 - 3851.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H.M. Fraser, S.E. Dickson, K.D. Morris, G.F. Erickson, and S.F. Lunn
The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate
Hum. Reprod., August 1, 1999; 14(8): 2054 - 2060.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K.E. Ratcliffe, F.W. Anthony, M.C. Richardson, and R.W. Stones
Morphology and functional characteristics of human ovarian microvascular endothelium
Hum. Reprod., June 1, 1999; 14(6): 1549 - 1554.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.